User contributions for Lazy
From Glioblastoma Treatments
Jump to navigationJump to search
12 August 2024
- 12:4512:45, 12 August 2024 diff hist +2,205 CBD No edit summary Tag: Visual edit: Switched
13 June 2024
- 20:1220:12, 13 June 2024 diff hist −4 Wilms Tumor 1 (WT1) Peptide Vaccine No edit summary current
- 20:1220:12, 13 June 2024 diff hist −573 Wilms Tumor 1 (WT1) Peptide Vaccine No edit summary
- 19:4919:49, 13 June 2024 diff hist +47 Category:Highly Useful Treatments No edit summary current
- 19:4819:48, 13 June 2024 diff hist +48 Category:Highly Useful Treatments No edit summary
- 19:4719:47, 13 June 2024 diff hist −22 Category:Highly Useful Treatments →Highly Useful Treatments
- 19:4519:45, 13 June 2024 diff hist −4 Anlotinib No edit summary current
- 19:4419:44, 13 June 2024 diff hist +2,897 N Anlotinib Created page with "{{TreatmentInfo |drug_name=Anlotinib |FDA_approval=Under investigation; not yet FDA-approved |used_for=Various cancers including Non-Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma, and Renal Cell Carcinoma; being investigated for Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase 2 and 3 (for different cancers); early-stage trials for GBM |common_side_effects=Hypertension, fatigue, hand-foot syndrome, diarrhea, proteinuria, thyroid dysfunction |OS_without=Med..."
- 19:2219:22, 13 June 2024 diff hist +83,438 Main Page No edit summary
29 May 2024
- 20:0220:02, 29 May 2024 diff hist +324 N Plotly Created page with "== Glioblastoma Treatments == <div id="categories"></div> <div id="plot"></div> <!-- Include Plotly script --> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <!-- Load the page-specific JavaScript --> <script src="/index.php?title=MediaWiki:InteractivePlot.js&action=raw&ctype=text/javascript"></script>" current
- 20:0020:00, 29 May 2024 diff hist +2,719 N MediaWiki:InteractivePlot.js Created page with "$(document).ready(function() { // Fetch the JSON data from the query result page fetch('https://glioblastomatreatments.wiki/index.php?title=Special:Ask/-5B-5BHas-20Usefulness-20Rating::%2B-5D-5D/-3FHas-20treatment-20name%3DTreatment-20Name/-3FHas-20Usefulness-20Rating%3DUsefulness-20Rating/-3FHas-20Toxicity-20Level%3DToxicity-20Level/-3FCategory/mainlabel%3D-2D/limit%3D100/offset%3D0/format%3Djson') .then(response => response.json()) .then(data => {..." current
- 19:5519:55, 29 May 2024 diff hist +2,834 N Plot Created page with "<div id="categories"></div> <div id="plot"></div> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <script> // Fetch the JSON data from the query result page fetch('https://glioblastomatreatments.wiki/index.php?title=Special:Ask/-5B-5BHas-20Usefulness-20Rating::%2B-5D-5D/-3FHas-20treatment-20name%3DTreatment-20Name/-3FHas-20Usefulness-20Rating%3DUsefulness-20Rating/-3FHas-20Toxicity-20Level%3DToxicity-20Level/-3FCategory/mainlabel%3D-2D/limit%3D1..." current
- 19:4819:48, 29 May 2024 diff hist −1 Treatments Plot No edit summary current
- 19:4819:48, 29 May 2024 diff hist +15 Treatments Plot No edit summary
- 19:4719:47, 29 May 2024 diff hist +4 Treatments Plot No edit summary
- 19:4719:47, 29 May 2024 diff hist −5 Treatments Plot No edit summary
- 19:4719:47, 29 May 2024 diff hist 0 Treatments Plot No edit summary
- 19:4619:46, 29 May 2024 diff hist −15 Treatments Plot No edit summary
- 19:4519:45, 29 May 2024 diff hist 0 Treatments Plot No edit summary
- 19:4519:45, 29 May 2024 diff hist 0 Treatments Plot No edit summary
- 19:4519:45, 29 May 2024 diff hist −32 Treatments Plot No edit summary
- 19:4419:44, 29 May 2024 diff hist +29 Treatments Plot No edit summary
- 19:4419:44, 29 May 2024 diff hist +20 Treatments Plot No edit summary
- 19:4319:43, 29 May 2024 diff hist +33 Treatments Plot No edit summary Tag: Manual revert
- 19:4219:42, 29 May 2024 diff hist −91 Treatments Plot No edit summary Tag: Reverted
- 19:4119:41, 29 May 2024 diff hist +92 Treatments Plot No edit summary Tag: Reverted
- 16:2016:20, 29 May 2024 diff hist −34 Treatments Plot No edit summary Tag: Reverted
- 16:1616:16, 29 May 2024 diff hist +59 Treatments Plot No edit summary
- 16:1616:16, 29 May 2024 diff hist −23 Treatments Plot No edit summary
- 16:1516:15, 29 May 2024 diff hist −56 Treatments Plot No edit summary
- 16:1316:13, 29 May 2024 diff hist +21 Treatments Plot No edit summary
- 16:1116:11, 29 May 2024 diff hist −17 Treatments Plot No edit summary
- 16:1016:10, 29 May 2024 diff hist −14 Treatments Plot No edit summary
- 16:0916:09, 29 May 2024 diff hist −2,314 Treatments Plot →Glioblastoma Treatments Tag: Replaced
- 16:0016:00, 29 May 2024 diff hist +2,530 N Treatments Plot Created page with "== Glioblastoma Treatments == <div id="categories"></div> <div id="plot"></div> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <script> // Fetch the JSON data from the query result fetch('/index.php?title=Special:Ask&format=json&q=Category:Treatments|%3FHas+treatment+name=Treatment|%3FHas+Effectiveness=Effectiveness|%3FHas+Toxicity=Toxicity|%3FHas+Category=Category|format=json|link=none|headers=hide|mainlabel=-') .then(response => resp..."
27 May 2024
- 16:1716:17, 27 May 2024 diff hist +101 Main Page →Glioblastoma
17 May 2024
- 19:1219:12, 17 May 2024 diff hist +3,163 N Metronomic low dose temozolomide (TMZ) Created page with "{{TreatmentInfo |drug_name=Metronomic Low-Dose Temozolomide (TMZ) |FDA_approval=FDA-approved for glioblastoma but standard metronomic dosing is still under investigation |used_for=Glioblastoma Multiforme (GBM), recurrent GBM |clinical_trial_phase=Phase II and III for metronomic dosing schedules |common_side_effects=Nausea, vomiting, fatigue, myelosuppression, lymphopenia |OS_without=Median overall survival for GBM is typically 15-17 months from diagnosis |OS_with=Studies..." current
- 09:0509:05, 17 May 2024 diff hist +356 Hyperthermia No edit summary current
- 09:0309:03, 17 May 2024 diff hist +1,629 N Hyperthermia Created page with "{{TreatmentInfo |drug_name=Hyperthermia |FDA_approval=Investigational |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase I/II |common_side_effects=Localized discomfort, potential damage to surrounding healthy tissue |OS_without=Standard progression statistics for GBM |OS_with=Extended survival reported in some clinical trials |PFS_without=Standard progression statistics for GBM |PFS_with=Improved progression-free survival in combination with other treatm..."
15 May 2024
- 15:1015:10, 15 May 2024 diff hist −1 Main Page No edit summary
- 15:0915:09, 15 May 2024 diff hist +166 Main Page →Tumor-associated antigen vaccines
- 15:0215:02, 15 May 2024 diff hist +8 Chronotherapy No edit summary current
- 15:0115:01, 15 May 2024 diff hist +1,583 N Chronotherapy Created page with "{{TreatmentInfo |drug_name=Chronotherapy with Temozolomide (TMZ) |FDA_approval=Yes (as part of standard glioblastoma treatment) |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Research ongoing |common_side_effects=Increased side effects when administered in the morning; however, these are generally manageable with other therapies. |OS_without=Around 19.5 months for patients with MGMT methylated tumors. |OS_with=Up to 17 months for general cases, and up to 2..."
28 April 2024
- 10:0110:01, 28 April 2024 diff hist −4 Main Page →Alternative Therapies Targeting GSCs
- 10:0010:00, 28 April 2024 diff hist −14 Main Page →Alternative Therapies Targeting GSCs
- 09:5709:57, 28 April 2024 diff hist +3,025 N Parthenolide Created page with "{{TreatmentInfo |drug_name=Parthenolide |FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma st..."
- 09:5509:55, 28 April 2024 diff hist −21 Metformin No edit summary
- 09:5309:53, 28 April 2024 diff hist +2,886 N Metformin Created page with "{{TreatmentInfo |drug_name=Metformin |FDA_approval=Yes (Approved for type 2 diabetes; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically studied for effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies and some clinical trials |clinical_trial_explanation=Metformin is under investigation for its potential anti-cancer properties in glioblastoma, particularly its effects on glioma stem ce..."
- 09:4909:49, 28 April 2024 diff hist +27 Sulforaphane No edit summary
- 09:4709:47, 28 April 2024 diff hist +2,892 N Sulforaphane Created page with "{{TreatmentInfo |drug_name=Sulforaphane |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, particularly in preclinical studies focusing on glioblastoma |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Sulforaphane is being studied in preclinical models for its potential as an anti-cancer agent against glioblastoma. Research focuses on its ability to inhibit histone..."
